Signaling through CD44 affects cell cycle progression and c-Jun expression in acute myeloid leukemia cells [Elektronische Ressource] / vorgelegt von Abdul Ali Peer Zada
Aus der Medizinischen Klinik und Poliklinik III-Gro?hadern-der Ludwig-Maximilians-Universit t M nchen, Vorstand: Prof. Dr. med. Wolfgang Hiddemann Signaling through CD44 affects cell cycle progression and c-Jun expression in acute myeloid leukemia cells Dissertation zum Erwerb des Doktorgrades der Humanbiologie an der Medizinischen Fakult t der Ludwig-Maximilians-Universit t zu M nchen Vorgelegt von Abdul Ali Peer Zada aus Tullamulla, Indien 2004 From the Department of Medicine III-Grosshadern Ludwig-Maximilians-University, Munich Chair: Prof. Dr. med. Wolfgang Hiddemann Signaling through CD44 affects cell cycle progression and c-Jun expression in acute myeloid leukemia cells Thesis Submitted for a Doctoral degree in Human Biology at the faculty of Medicine Ludwig-Maximilians-University, Munich Submitted by Abdul Ali Peer Zada From Tullamulla, India 2004 Mit Genehmigung der Medizinischen Fakult t der Universit t M nchen 1. Berichterstatter: Prof. Dr. W.
Table of ContentsPage No.1. Introduction 5 1.1 Hematopoietic differentiation and AML 1.2 Induction of differentiation: differentiation therapy in AML 1.3 Adhesion Receptor CD44 13 1.3.1 CD44: Role in hematopoiesis 16 1.3.2 CD44 in AML: Role as therapeutic target16 1.4 Transcription factorc-jun 17 1.4.1 Role in proliferation and cell cycle 18 1.4.2 Cell cycle 20 1.4.3 Regulation ofc-jun 21 1.4.3.1 Transcriptional level 21 1.4.3.2 Post-translational level 22 1.4.3.3 Protein-protein interaction level 23 1.5 Aim of the study 24 2. Materials 25 2.1 Mammalian cell lines 2.2 Plasmids 2.3 Antibodies 3. Methods 26 3.1 Proliferation assays 26 3.1.1 MTT assay 3.2.2 BrdU assay
1
3.2 Cell cycle analysis and flow cytometry 27 3.3 RNA isolation and semi-quantitative RT-PCR 28 3.4 Quantitative Real time PCR in AML patients 29 3.5 Immunoblot analysis 30 3.6 Immunocomplex kinase assay 31 3.7 Transient transfections using effectene 31 3.8 Stable cell lines overexpressing c-jun 32 4. Results 33 4.1 CD44 ligation inhibits the proliferation and induces terminal differentiation of myeloid leukaemia cells 33 4.2 CD44 ligation with A3D8 induces G0/G1 arrest 39 4.3 CD44 ligation induces p21 and downregulates G1 41 regulatory proteins 4.4 CD44 ligation inhibits cyclin dependent kinase activity 41 4.5 CD44 ligation decreasesc-junmRNA and protein 45 expressions 4.6 CD44 ligation decreasesc-junpromoter activity 45 4.7 A3D8 treatment decreasesc-Junphosphorylation 51 and JNK expression 4.8 Overexpression ofc-Jun 51overcomes anti-proliferative effects of A3D8 5. Discussion 57 6. Summary 65
2
82
84
k
this wor
om
fr
ublished paper
11. P
10. Lebenslauf
3
66
67
8. Refer
enfassung
m
7. Zusam
ences
ents
9. Acknowledgem
To Abba, Amma & Gazalla, Feham
4
1 Introduction
1.1 Hematopoietic differentiation and acute myeloid leukemia (AML)
A cellular evolution of the pluripotential haematopoietic stem cells (HSCs) that normally leads to mature functional blood cells constitutes what is termed as hematopoiesis. Hematopoiesis is a very elaborate, sophisticated and dynamic physiological process. The bone marrow of a normal man weighing 70 kg produces each day some 210 x 108 mature erythrocytes, 175 x 108platelet, and 60 x 108neutrophil granulocytes (Mary et al.,1980).
Figure 1. Haematopoietic development from a stem cell and
role of transcription factors (Tenen, 2003)
During a 70-year life of an individual, approximately 650 kg of erythrocytes and 1000 kg of white blood cells are produced by the hematopoitic system (Afenya, 1996). In the hematopoietic development model, mature myeloid cells develop from hematopoietic stem cells through progenitors that